DK1537867T3 - Fremgangsmåde til fotodynamisk diagnosticering af vaskulære sygdomme - Google Patents
Fremgangsmåde til fotodynamisk diagnosticering af vaskulære sygdommeInfo
- Publication number
- DK1537867T3 DK1537867T3 DK03733569T DK03733569T DK1537867T3 DK 1537867 T3 DK1537867 T3 DK 1537867T3 DK 03733569 T DK03733569 T DK 03733569T DK 03733569 T DK03733569 T DK 03733569T DK 1537867 T3 DK1537867 T3 DK 1537867T3
- Authority
- DK
- Denmark
- Prior art keywords
- photodynamic
- iminochlorinaspartic
- remedies
- acceptable salt
- acid derivative
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000019553 vascular disease Diseases 0.000 title 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 238000002428 photodynamic therapy Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 1
- 208000001126 Keratosis Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 210000005005 sentinel lymph node Anatomy 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002185296A JP4394334B2 (ja) | 2002-06-25 | 2002-06-25 | 脈管病に関する光物理化学的診断・治療薬 |
| PCT/JP2003/008016 WO2004000308A1 (ja) | 2002-06-25 | 2003-06-25 | 脈管病に関する光物理化学的・診断方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1537867T3 true DK1537867T3 (da) | 2008-11-10 |
Family
ID=29996731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03733569T DK1537867T3 (da) | 2002-06-25 | 2003-06-25 | Fremgangsmåde til fotodynamisk diagnosticering af vaskulære sygdomme |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20050209298A1 (da) |
| EP (2) | EP1847267A3 (da) |
| JP (1) | JP4394334B2 (da) |
| KR (1) | KR100837136B1 (da) |
| AT (1) | ATE404194T1 (da) |
| AU (1) | AU2003243968B2 (da) |
| CA (1) | CA2490326C (da) |
| DE (1) | DE60322918D1 (da) |
| DK (1) | DK1537867T3 (da) |
| ES (1) | ES2312788T3 (da) |
| PT (1) | PT1537867E (da) |
| WO (1) | WO2004000308A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2006085517A1 (ja) * | 2005-02-08 | 2008-06-26 | 株式会社光ケミカル研究所 | クロリン類及びポルフィリン類のｐｄｔ用軟膏製剤及び坐剤 |
| US20110160642A1 (en) * | 2007-11-15 | 2011-06-30 | Wolfgang Neuberger | Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
| JP5179245B2 (ja) * | 2008-04-30 | 2013-04-10 | 功 阪田 | 皮膚疾患治療剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5368841A (en) * | 1993-02-11 | 1994-11-29 | The General Hospital Corporation | Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides |
| JP3718887B2 (ja) * | 1995-10-30 | 2005-11-24 | 株式会社光ケミカル研究所 | ポルフィリン誘導体とその用途 |
| ATE244244T1 (de) * | 1996-10-01 | 2003-07-15 | Wyeth Lederle Japan Ltd | Iminochlorinasparaginsaeure-derivate |
| DE19960705A1 (de) * | 1999-12-16 | 2001-06-21 | Laser & Med Tech Gmbh | Verfahren und Vorrichtung zur Herstellung eines autologen Immunisierungsimpfstoffes gegen Krebserkrankungen (Tumorvakzine) |
| JP2003012547A (ja) * | 2001-06-27 | 2003-01-15 | Meiji Seika Kaisha Ltd | インスリン依存性糖尿病の診断剤および治療剤 |
-
2002
- 2002-06-25 JP JP2002185296A patent/JP4394334B2/ja not_active Expired - Fee Related
-
2003
- 2003-06-25 ES ES03733569T patent/ES2312788T3/es not_active Expired - Lifetime
- 2003-06-25 US US10/518,814 patent/US20050209298A1/en not_active Abandoned
- 2003-06-25 KR KR1020047020956A patent/KR100837136B1/ko not_active IP Right Cessation
- 2003-06-25 EP EP07014305A patent/EP1847267A3/en not_active Withdrawn
- 2003-06-25 DE DE60322918T patent/DE60322918D1/de not_active Expired - Lifetime
- 2003-06-25 CA CA2490326A patent/CA2490326C/en not_active Expired - Fee Related
- 2003-06-25 AT AT03733569T patent/ATE404194T1/de active
- 2003-06-25 DK DK03733569T patent/DK1537867T3/da active
- 2003-06-25 WO PCT/JP2003/008016 patent/WO2004000308A1/ja active IP Right Grant
- 2003-06-25 AU AU2003243968A patent/AU2003243968B2/en not_active Ceased
- 2003-06-25 PT PT03733569T patent/PT1537867E/pt unknown
- 2003-06-25 EP EP03733569A patent/EP1537867B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE404194T1 (de) | 2008-08-15 |
| JP2004026717A (ja) | 2004-01-29 |
| CA2490326C (en) | 2010-09-07 |
| WO2004000308A1 (ja) | 2003-12-31 |
| PT1537867E (pt) | 2008-10-09 |
| EP1847267A3 (en) | 2010-07-07 |
| EP1537867B1 (en) | 2008-08-13 |
| ES2312788T3 (es) | 2009-03-01 |
| CA2490326A1 (en) | 2003-12-31 |
| AU2003243968A1 (en) | 2004-01-06 |
| KR100837136B1 (ko) | 2008-06-11 |
| US20050209298A1 (en) | 2005-09-22 |
| AU2003243968B2 (en) | 2008-01-31 |
| KR20050016619A (ko) | 2005-02-21 |
| JP4394334B2 (ja) | 2010-01-06 |
| DE60322918D1 (de) | 2008-09-25 |
| EP1537867A1 (en) | 2005-06-08 |
| EP1847267A2 (en) | 2007-10-24 |
| EP1537867A4 (en) | 2006-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1558616T3 (da) | Meso-substituerede porphyriner | |
| BRPI0512108A (pt) | antibióticos contendo complexos de ácido borìnico e métodos de uso | |
| BRPI0510560A (pt) | pirido[2,3-d] pirimidin-7-onas pirrolil substituìdas e seus derivados como agentes terapêuticos | |
| BRPI0513750A (pt) | 2-fenilamino-benzamidas-5-substituìdas como inibidoras de mek | |
| BRPI0418939A (pt) | derivados de nicotinamida e sua utilização como agentes terapêuticos | |
| BR0317564A (pt) | Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos | |
| WO2008084241A3 (en) | Use of aminolevulinic acid and derivatives thereof | |
| ATE453646T1 (de) | 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren | |
| BRPI0512049A (pt) | usos antivirais de complexos de ácido borìnico | |
| MX2007004861A (es) | Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias. | |
| GT200300034A (es) | Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades | |
| WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
| WO2004110151A8 (en) | Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments | |
| NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
| SE0203304D0 (sv) | Novel Coumpounds | |
| WO2020176654A8 (en) | Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents | |
| DK1537867T3 (da) | Fremgangsmåde til fotodynamisk diagnosticering af vaskulære sygdomme | |
| EA200500500A1 (ru) | Новые антимикобактериальные соединения | |
| TW200610530A (en) | Anti-parasitic uses of borinic acid complexes | |
| ATE369366T1 (de) | S-tenatoprazolnatrium-monohydrat-salz und dessen verwendung in form eines protonenpumpenhemmers | |
| DE60206599D1 (de) | Biotin-derivate und ihre konjugaten mit chelatierungsmitteln | |
| ATE479695T1 (de) | Sulfopyranosylacylglycerol-derivate zur anwendung in kombination mit bestrahlung in einer tumor- radiotherapie | |
| EA200401302A1 (ru) | Лекарственные средства, содержащие бетамиметики и новое антихолинергическое средство | |
| WO2005035500A3 (en) | Therapeutic agents useful for treating pain | |
| TH62592A (th) | ฟลูออรีนคาร์บอกซีลิกแอซิดเอสเทอร์ใหม่ กรรมวิธีสำหรับการผลิตของสารนั้น และการใช้สารนั้นเป็นสารรักษาโรค |